CHAPTER 1 INTRODUCTION
1.1. Market Definition
1.2. Executive Summary
1.3. The Scope of the Study
CHAPTER 2 RESEARCH METHODOLOGY
2.1. Secondary Research
2.2. Primary Research
2.3. Analytic Tools and Model
2.4. Economic Indicator
2.4.1. Base Year, Base Currency, Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
CHAPTER 3 MARKET ANALYSIS
3.1. Industry Value Chain Analysis
3.2. Porter's Five Force Analysis
3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Threats of Substitutes
3.2.4. Threats of New Entrants
3.2.5. Degree of Competition
3.3. PESTLE Analysis
3.3.1. Political
3.3.2. Economical
3.3.3. Social
3.3.4. Technological
3.3.5. Legal
3.3.6. Environmental
3.4. SWOT Analysis
3.4.1. Strengths
3.4.2. Weakness
3.4.3. Opportunities
3.4.4. Threats
3.5. Y-O-Y Analysis
CHAPTER 4 MARKET DYNAMICS
4.1. Market Drivers
4.1.1. Development of novel and safe drugs
4.1.2. Government policies about drug safety regulations
4.1.3. Increasing incidence rates of adverse drug reactions
4.1.4. Increasing adoption of pharmacovigilance software by outsourcing companies
4.2. Market Restraints & Challenges
4.2.1. Lack of pharmacovigilance professionals
4.2.2. Shortage of standard regulations
4.3. Market Opportunities
4.3.1. Emerging economies
4.3.2. Increasing the implementation rate of this drug safety software
CHAPTER 5 GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET – BY
FUNCTIONALITY
5.1. Introduction
5.2. Adverse event reporting software
5.3. Drug safety audits software
5.4. Issue tracking software
5.5. Fully integrated software
CHAPTER 6 GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET – BY
DELIVERY MODE
6.1. Introduction
6.2. On-Premise delivery mode
6.3. On-Demand/Cloud based delivery mode
CHAPTER 7 GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET – BY END-USERS
7.1. Introduction
7.2. Pharma and biotech companies
7.3. Contract research organizations (CROS)
7.4. Business process outsourcing (BPO) Firms
7.5. Other pharmacovigilance service providers
CHAPTER 8 GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET - BY
GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. U.S.
8.2.2. Canada
8.2.3. Mexico
8.2.4. Costa Rica
8.3. South America
8.3.1. Brazil
8.3.2. Argentina
8.3.3. Chile
8.3.4. Columbia
8.3.5. Others
8.4. Europe
8.4.1. U.K.
8.4.2. Germany
8.4.3. France
8.4.4. Italy
8.4.5. Spain
8.4.6. Russia
8.4.7. Netherlands
8.4.8. Switzerland
8.4.9. Poland
8.4.10. Others
8.5. Asia Pacific
8.5.1. China
8.5.2. Japan
8.5.3. India
8.5.4. South Korea
8.5.5. Australia & New Zealand
8.5.6. Malaysia
8.5.7. Singapore
8.5.8. Others
8.6. Middle East & Africa
8.6.1. UAE
8.6.2. Saudi Arabia
8.6.3. Iran
8.6.4. Iraq
8.6.5. Qatar
8.6.6. South Africa
8.6.7. Algeria
8.6.8. Morocco
8.6.9. Nigeria
8.6.10. Egypt
8.6.11. Others
CHAPTER 9 GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET - COMPANY PROFILES
9.1. Ab Cube
9.2. ArisGlobal LLC
9.3. Ennov Solutions, Inc.
9.4. Extedo GmbH
9.5. Online Business Applications, Inc.
9.6. Oracle Corporation.
9.7. Sarjen Systems P.v.t Ltd.
9.8. Sparta Systems, Inc.
9.9. Umbra Global LLC
9.10. United BioSource Corporation
9.11. Relsys International, Inc.
9.12. Max Application.
CHAPTER 10 GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET –
COMPETITIVE LANDSCAPE
10.1. Market Share Analysis
10.2. Strategies adopted by top companies
10.3. Mergers, Acquisitions, Collaborations & Agreements
CHAPTER 11 MARKET INSIGHTS
11.1. Industry Experts Insights
11.2. Analysts Opinions
11.3. Investment Opportunities
CHAPTER 12 APPENDIX
12.1. List of Tables
12.2. List of Figures
